Artificial intelligence-based strategies to identify patient populations and advance analysis in age-related macular degeneration clinical trials.

Journal: Experimental eye research
Published Date:

Abstract

No abstract available for this article.

Authors

  • Antonio Yaghy
    A research intern at the Ocular Oncology Service at Wills Eye Hospital in Philadelphia, Pennsylvania, and is interested in ophthalmology.
  • Aaron Y Lee
    Department of Ophthalmology, University of Washington, Seattle, Washington.
  • Pearse A Keane
    National Institute for Health Research Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK.
  • Tiarnan D L Keenan
    Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland.
  • Luísa S M Mendonça
    New England Eye Center, Tufts Medical Center, Boston, Massachusetts.
  • Cecilia S Lee
    Department of Ophthalmology, University of Washington, Seattle, Washington, USA.
  • Anne Marie Cairns
    Optos Plc, Dunfermline, Scotland, United Kingdom.
  • Joseph Carroll
    Medical College of Wisconsin, Milwaukee, WI, USA.
  • Hao Chen
    The First School of Medicine, Wenzhou Medical University, Wenzhou, China.
  • Julie Clark
    Chemical Biology and Therapeutics Department, St. Jude Children's Research Hospital , Memphis, Tennessee 38105, United States.
  • Catherine A Cukras
    Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Luis de Sisternes
    Carl Zeiss Meditec, Inc, Dublin, CA, USA.
  • Amitha Domalpally
    Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI, United States of America.
  • Mary K Durbin
    Carl Zeiss Meditec, Inc, Dublin, CA, USA.
  • Kerry E Goetz
    Office of the Director, National Eye Institute, National Institutes of Health, Bethesda, MD, USA.
  • Felix Grassmann
    Institute of Human Genetics, University of Regensburg, Regensburg, Germany.
  • Jonathan L Haines
    Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA; Cleveland Institute of Computational Biology, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
  • Naoto Honda
    Nidek, CO. LTD, Aichi, Japan.
  • Zhihong Jewel Hu
    Doheny Eye Institute, Los Angeles, CA, 90033, USA. jhu@doheny.org.
  • Christopher Mody
    Heidelberg Engineering, Heidelberg, Germany.
  • Luz D Orozco
    Department of Bioinformatics, Genentech, South San Francisco, CA, 94080, USA.
  • Cynthia Owsley
    Department of Ophthalmology and Visual Sciences, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Stephen Poor
    Department of Ophthalmology, Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Charles Reisman
    Heidelberg Engineering, Heidelberg, Germany.
  • Ramiro Ribeiro
    Apellis Pharmaceuticals, Waltham, MA, USA.
  • SriniVas R Sadda
    Doheny Image Analysis Laboratory, Doheny Eye Institute, Los Angeles, CA, USA.
  • Sobha Sivaprasad
    Moorfields Eye Hospital City Road Campus, London, UK.
  • Giovanni Staurenghi
    Department of Biomedical and Clinical Sciences Luigi Sacco, Luigi Sacco Hospital, University of Milan, Italy.
  • Daniel Sw Ting
    Singapore Eye Research Institute, Singapore National Eye Centre, Singapore.
  • Santa J Tumminia
    Office of the Director, National Eye Institute, National Institutes of Health, Bethesda, MD, USA.
  • Luca Zalunardo
    Icare USA Inc, Raleigh, NC, USA.
  • Nadia K Waheed
    New England Eye Center, Tufts Medical Center, Boston, Massachusetts.